Syndax Pharmaceuticals Inc Quarterly Return On Equity in % from Q3 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Syndax Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from Q3 2016 to Q3 2024.
  • Syndax Pharmaceuticals Inc Return On Equity for the quarter ending September 30, 2024 was -64.3 %, a 51.8% decline year-over-year.
  • Syndax Pharmaceuticals Inc annual Return On Equity for 2023 was -47.9 %, a 23.6% decline from 2022.
  • Syndax Pharmaceuticals Inc annual Return On Equity for 2022 was -38.7 %, a 508% decline from 2021.
  • Syndax Pharmaceuticals Inc annual Return On Equity for 2021 was 9.49 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -64.3 -22 -51.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -57.4 -18.3 -46.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -53.3 -15.1 -39.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -47.9 -9.15 -23.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -42.4 -38.6 -1026% Jul 1, 2023 Sep 30, 2023
Q2 2023 -39.1 -39.3 -16149% Apr 1, 2023 Jun 30, 2023
Q1 2023 -38.3 -43.4 -839% Jan 1, 2023 Mar 31, 2023
Q4 2022 -38.7 -48.2 -508% Oct 1, 2022 Dec 31, 2022
Q3 2022 -3.76 +37.3 +90.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 0.24 +44.5 Apr 1, 2022 Jun 30, 2022
Q1 2022 5.18 +50.3 Jan 1, 2022 Mar 31, 2022
Q4 2021 9.49 +59.5 Oct 1, 2021 Dec 31, 2021
Q3 2021 -41 +32.2 +43.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -44.3 +41.2 +48.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -45.1 +78.5 +63.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -50 +62.4 +55.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -73.2 +37 +33.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -85.4 +23 +21.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -124 -16.1 -15% Jan 1, 2020 Mar 31, 2020
Q4 2019 -112 -4.62 -4.29% Oct 1, 2019 Dec 31, 2019
Q3 2019 -110 -19.1 -21% Jul 1, 2019 Sep 30, 2019
Q2 2019 -108 -28.1 -35% Apr 1, 2019 Jun 30, 2019
Q1 2019 -107 -39.8 -58.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -108 -44.2 -69.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -91.1 -33.2 -57.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -80.4 -22.1 -38% Apr 1, 2018 Jun 30, 2018
Q1 2018 -67.7 -14.9 -28.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 -63.5 -18.8 -42.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -57.9 +195 +77.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -58.2 Apr 1, 2017 Jun 30, 2017
Q1 2017 -52.8 Jan 1, 2017 Mar 31, 2017
Q4 2016 -44.7 Oct 1, 2016 Dec 31, 2016
Q3 2016 -253 Jul 1, 2016 Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.